Tracon Pharmaceuticals, Inc.
Tracon Pharmaceuticals, Inc. (TCON) is a publicly traded company in the Unknown sector. Across all available filings, 37 corporate insiders have executed 292 transactions totaling $161.7M, demonstrating a bullish sentiment with $148.4M in net insider flow. The most recent transaction on Nov 10, 2023 involved a sale of 4,324,008 shares valued at $1.3M.
TCON Insider Activity Summary
Who Is Buying TCON Stock?
No significant insider buying has been recorded for TCON in the recent period.
Who Is Selling TCON Stock?
No significant insider selling has been recorded for TCON in the recent period.
Is Tracon Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for TCON is bullish with an Insider Alignment Score of 96/100 and a net flow of $148.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
TCON Frequently Asked Questions
Understanding TCON Insider Activity
Insider trading at Tracon Pharmaceuticals, Inc. (TCON) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 37 insiders are actively trading TCON stock, having executed 292 transactions in the past 90 days. The most active insider is Partners 14, L.p. Nea (Executive), who has made 5 transactions totaling $12.6M.
Related Tools
Track Tracon Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at TCON file new Form 4 transactions